Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
FRONT PAGE STOCKS
(Total Views: 82)
Posted On: 12/21/2023 3:39:11 PM
Post# of 43997
Avatar
Posted By: budfoxfun
$RNXT The pivotal Phase III CouGar study will be the second clinical trial evaluating RenovoGem™, a combination drug-device product, in a difficult-to-access solid tumor cancer. Learn more: https://bit.ly/4asSZjH

$RNXT #BileDuctCancer https://twitter.com/RenovoRx/status/1737914614195577273

(0)
(0)








  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site